HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Andersen Tawil syndrome — Clinical Guidelines

Overview

Andersen-Tawil syndrome (ATS) is a rare autosomal dominant channelopathy characterized by periodic paralysis, cardiac arrhythmias, and distinctive facial and skeletal features, often linked to mutations in the KCNJ2 gene encoding the Kir2.1 potassium channel. 1 4 6 10

Diagnosis

Genetic Testing: Identification of mutations in KCNJ2 or KCNJ5 genes is crucial 1 6 10.

Clinical Criteria: Presence of periodic paralysis, ventricular arrhythmias, and dysmorphic features 4 6.

Electrocardiogram (ECG) Findings: TU wave abnormalities and ventricular bigeminy patterns may be observed 5 3.

Holter Monitoring: Reveals frequent premature ventricular contractions (PVCs) and bigeminy episodes 3.

Facial Analysis: Three-dimensional stereophotogrammetric analysis can aid in diagnosis, especially in cases without genetic confirmation 4.

Management

Arrhythmia Control: Flecainide has shown efficacy in suppressing bidirectional ventricular tachycardia 11.

Symptomatic Treatment: Management of periodic paralysis and muscle weakness may involve supportive care and lifestyle adjustments 1 9.

Cardiac Monitoring: Regular ECG and Holter monitoring to track arrhythmias 2 3.

Genetic Counseling: Essential for families with known mutations 6 7.

Special Populations

Pediatrics: Early onset of symptoms like muscle weakness can guide early intervention 6.

Comorbidities: Patients with a history of sudden cardiac arrest may require implantable cardioverter-defibrillators (ICDs) 2.

Key Recommendations

Genetic Testing for Diagnosis: Confirm diagnosis through genetic analysis of KCNJ2 and KCNJ5 genes (Evidence: Strong 1 6 10).

Use of Flecainide for Arrhythmias: Consider flecainide for managing bidirectional ventricular tachycardia (Evidence: Moderate 11).

Regular Cardiac Monitoring: Implement continuous ECG monitoring to manage and detect arrhythmias (Evidence: Moderate 2 3).

Genetic Counseling for Families: Provide genetic counseling to families with identified mutations (Evidence: Expert opinion 6).

References

1 Anderson CL, Munuwar S, Walters JK, McWilliams SF, Melnick M, Langer ER et al.. Large-scale functional assessment of variants of the potassium channel Kir2.1: Clinical and comparative insights. The Journal of biological chemistry 2026. link 2 Biernacka EK, Stec SM, Krych M, Ogorzelec N, Kowalewski M, Suwalski P. Elective percutaneous stellate ganglion block for prediction of the clinical outcome of robotic bilateral cardiac sympathetic denervation in a patient with Andersen-Tawil syndrome: A case report. European journal of anaesthesiology 2026. link 3 Lerma C, Manzano-Cabada J, Valencia P, Márquez-Murillo MF. Ventricular bigeminy characterization in 24-h Holter monitoring from Andersen-Tawil patients: An initial proof of concept versus patients with ischemic heart disease. Journal of electrocardiology 2023. link 4 Dolci C, Sansone VA, Gibelli D, Cappella A, Sforza C. Distinctive facial features in Andersen-Tawil syndrome: A three-dimensional stereophotogrammetric analysis. American journal of medical genetics. Part A 2021. link 5 Horigome H, Ishikawa Y, Kokubun N, Yoshinaga M, Sumitomo N, Lin L et al.. Multivariate analysis of TU wave complex on electrocardiogram in Andersen-Tawil syndrome with KCNJ2 mutations. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2020. link 6 Ardissone A, Sansone V, Colleoni L, Bernasconi P, Moroni I. Intrafamilial phenotypic variability in Andersen-Tawil syndrome: A diagnostic challenge in a potentially treatable condition. Neuromuscular disorders : NMD 2017. link 7 Hasegawa K, Ohno S, Kimura H, Itoh H, Makiyama T, Yoshida Y et al.. Mosaic KCNJ2 mutation in Andersen-Tawil syndrome: targeted deep sequencing is useful for the detection of mosaicism. Clinical genetics 2015. link 8 Munoz C, Almilaji A, Setiawan I, Föller M, Lang F. Up-regulation of the inwardly rectifying K⁺ channel Kir2.1 (KCNJ2) by protein kinase B (PKB/Akt) and PIKfyve. The Journal of membrane biology 2013. link 9 Seebohm G, Strutz-Seebohm N, Ursu ON, Preisig-Müller R, Zuzarte M, Hill EV et al.. Altered stress stimulation of inward rectifier potassium channels in Andersen-Tawil syndrome. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2012. link 10 Kim JB, Chung KW. Novel de novo mutation in the KCNJ2 gene in a patient with Andersen-Tawil syndrome. Pediatric neurology 2009. link 11 Pellizzón OA, Kalaizich L, Ptácek LJ, Tristani-Firouzi M, Gonzalez MD. Flecainide suppresses bidirectional ventricular tachycardia and reverses tachycardia-induced cardiomyopathy in Andersen-Tawil syndrome. Journal of cardiovascular electrophysiology 2008. link 12 Seemann G, Sachse FB, Weiss DL, Ptácek LJ, Tristani-Firouzi M. Modeling of IK1 mutations in human left ventricular myocytes and tissue. American journal of physiology. Heart and circulatory physiology 2007. link 13 Ma D, Tang XD, Rogers TB, Welling PA. An andersen-Tawil syndrome mutation in Kir2.1 (V302M) alters the G-loop cytoplasmic K+ conduction pathway. The Journal of biological chemistry 2007. link 14 Bendahhou S, Donaldson MR, Plaster NM, Tristani-Firouzi M, Fu YH, Ptácek LJ. Defective potassium channel Kir2.1 trafficking underlies Andersen-Tawil syndrome. The Journal of biological chemistry 2003. link

Andersen Tawil syndrome